Enthusiasm With EGFR Exon 20+ in NSCLC

EP: 1.Kicking Off With KRAS in NSCLC

Now Viewing

EP: 2.Enthusiasm With EGFR Exon 20+ in NSCLC

EP: 3.What’s Next in HER2+ and Exon 19 Deletions in NSCLC?

EP: 4.ASCO 2021 Updates With Neoadjuvant Immunotherapy in NSCLC

EP: 5.Circling the Latest With ctDNA in Lung Cancer

Joshua K. Sabari, MD; Jamie Chaft, MD; and Vamsidhar Velcheti, MD, highlight the intriguing data in the realm of EGFR exon 21 insertion mutations in non–small cell lung cancer presented during the 2021 ASCO Annual Meeting.

The episode is part of the third series of Thoracic Night Live, a program devoted to spotlighting the biggest topics in lung cancer and pivotal studies discussed at medical meetings throughout the year.